|
|
||||||||
1 Department of Kinesiology and 2 Department of Neurology and Physical Medicine and Rehabilitation, McMaster University, Hamilton, Ontario, Canada L8S 4K1; and 3 Metabolism Division, Washington University School of Medicine, St. Louis, Missouri 63110
Roy, B. D., M. A. Tarnopolsky, J. D. MacDougall, J. Fowles,
and K. E. Yarasheski. Effect of glucose supplement timing on
protein metabolism after resistance training. J. Appl.
Physiol. 82(6): 1882-1888, 1997.
We determined
the effect of the timing of glucose supplementation on fractional
muscle protein synthetic rate (FSR), urinary urea excretion, and whole
body and myofibrillar protein degradation after resistance exercise.
Eight healthy men performed unilateral knee extensor exercise (8 sets/~10 repetitions/~85% of 1 single maximal repetition). They
received a carbohydrate (CHO) supplement (1 g/kg) or placebo (Pl)
immediately (t = 0 h) and 1 h
(t = +1 h) postexercise. FSR was
determined for exercised (Ex) and control (Con) limbs by incremental
L-[1-13C]leucine
enrichment into the vastus lateralis over ~10 h postexercise. Insulin
was greater (P < 0.01) at 0.5, 0.75, 1.25, 1.5, 1.75, and 2 h, and glucose was greater
(P < 0.05) at 0.5 and 0.75 h for CHO compared with Pl condition. FSR was 36.1% greater in the CHO/Ex leg than in the CHO/Con leg
(P = not significant) and
6.3% greater in the Pl/Ex leg than in the Pl/Con leg
(P = not significant). 3-Methylhistidine excretion was lower in the CHO (110.43 ± 3.62 µmol/g creatinine) than Pl condition (120.14 ± 5.82, P < 0.05) as was urinary urea
nitrogen (8.60 ± 0.66 vs. 12.28 ± 1.84 g/g creatinine,
P < 0.05). This suggests that CHO
supplementation (1 g/kg) immediately and 1 h after resistance exercise
can decrease myofibrillar protein breakdown and urinary urea excretion,
resulting in a more positive body protein balance.
muscle protein synthesis; protein degradation; 3-methylhistidine; urea nitrogen; and insulin
MUSCLE GROWTH in adult humans results from muscle fiber
hypertrophy (11). Hypertrophy is the result of an increased net muscle
protein balance [i.e., fractional muscle protein synthetic rate
(FSR) Research in the area of resistance training and its effects on FSR and
MPD is limited. Recent work from independent laboratories has shown
that FSR was elevated after a bout of resistance training in humans (4,
6). Net protein balance, although more positive, was still negative
after resistance exercise in the fasted state (4). In addition, it has
been demonstrated that in the fed state, strength-trained individuals
have a net positive whole body protein balance and an elevated whole
body protein synthesis rate (WBPS) and amino acid flux
compared with sedentary individuals (23). These inconsistencies may
relate to the availability of amino acids and energy status during the
hyperinsulinemic state (2).
It appears that, when insulin is combined with increased amino
acid delivery, FSR and WBPS are increased (2). The importance of
insulin in suppressing or attenuating the increase in MPD after exercise may be of particular importance in the postexercise period (4).
Studies to date have not addressed the potential interaction of
resistance exercise and insulin/nutritional state on leucine turnover/protein balance. Because insulin may cause a decrease in MPD,
and a possible increase in FSR, and resistance exercise is known to
increase FSR, it is possible that insulin could decrease MPD and
increase FSR simultaneously after a bout of resistance exercise. If the
latter occurs in combination with the increase in FSR due to the
exercise (4, 6), the net protein balance would be even more positive,
thus resulting in a greater net accretion of myofibrillar protein. The
consumption of a carbohydrate (CHO) supplement is a simple method of
increasing insulin concentrations after exercise (9, 32).
We hypothesized that a CHO supplement consumed immediately after
resistance exercise would result in
1) decreased urinary 3-methylhistidine (3-MH) excretion (a marker of MPD),
2) increased muscle
[13C]leucine
incorporation rate (increased FSR), and 3) decreased urinary urea nitrogen excretion (net positive protein balance).
muscle protein degradation rate (MPD)]. Both FSR (4, 6, 30) and MPD (4) can be stimulated by heavy-resistance exercise
in humans. It is also known that amino acid transport is increased
after resistance exercise (3). Further understanding of the factors
influencing net protein balance may allow the ability to maximize FSR
and minimize MPD, thus maximizing the rate and amount of muscle
hypertrophy.
Subjects.
Eight healthy young (aged 20-25 yr) men who had been participating
in a resistance training program for at least 1 yr before the
investigation (
2 times/wk) were recruited as subjects (Table 1). The experimental procedures, possible
risks, and benefits were explained to each volunteer before written
consent was obtained. The study was approved by the McMaster University
Human Ethics Committee.
Table 1.
Subjects' descriptive data
Subject No.
Age, yr
Mass, kg
Height, cm
%Body Fat
Energy, kcal/day
%CHO
%Fat
%Pro
1
24
73.5
176
16.8
2990
68
22
10
2
27
77
175
11.2
2863
63
25
12
3
21
76.3
174
15.6
2674
64
23
12
4
19
79.6
172
18.1
2533
65
24
12
5
21
73.8
182
21.4
3176
62
26
12
6
18
63
167
12.7
3091
61
27
13
7
21
87.4
187
17.8
2593
69
20
11
8
21
69.2
173
18.4
2056
74
16
10
Mean ± SD
21.5 ± 2.8
75.0 ± 7.2
175.8 ± 6.2
16.5 ± 3.3
2747 ± 363.9
65.8 ± 4.3
22.9 ± 3.6
11.5 ± 1.1
CHO, carbohydrate; Pro, protein.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
120 min). A 20-gauge catheter was inserted into an antecubital
vein for tracer infusion, as described by Tarnopolsky et al. (23, 24).
A second catheter was placed into a contralateral dorsal hand vein for "arterialized" blood sampling (hot box at 65 ± 5°C) (16).
A primed (0.972 ± 0.03 mg/kg) constant (0.977 ± 0.02 mg · kg
1 · h
1)
infusion of
L-[1-13C]leucine
(Masstrace, Somerville, MA) was used to determine mixed muscle protein FSR as previously described (6, 23, 30). The infusate
was passed through an antibacterial filter (0.2 µm; Acrodisc)
immediately before infusion. At ~1830
(t =
30 min), subjects
performed the prescribed weight training bout [4 sets each of
unilateral leg press and knee extension, 85% of 1 maximal repetition
(RM), 8-10 repetitions]. The 90 min between the start of the
infusion and the onset of exercise was to ensure that an isotopic
plateau had been achieved (23). Immediately after exercise (~1900;
t = 0), a blood sample was
drawn, a muscle sample was taken from the vastus lateralis muscle of
each leg (post-Ex0, post-Con0) by using a
suction-modified Bergstöm biopsy needle (Stille), and the glucose
(1 g/kg) or Nutrasweet drink was consumed. Blood samples (4 ml) were
collected every 15 min for the next hour and immediately centrifuged
and stored at
50°C. At ~2030 (t = +1 h) a second CHO (1 g/kg) or Pl
drink was administered. Blood samples were again collected every 15 min
for the next 1.5 h and again at ~0400, 0430, and 0500 the next
morning. Final biopsy specimens where taken at ~0500
(post-Ex10,
post-Con10; ~10-h incorporation time). The subjects also collected all urine excreted during the 24-h
period (~12 h pre-Ex, ~12 h post-Ex) for subsequent creatinine, 3-MH, and urea nitrogen determination. Sample collection began in the
morning (0600) of the trial (first urination not collected) and
continued through to the following morning (0600). Diets were isoenergetic and isonitrogenous during this collection period. The
subjects did not leave the laboratory until the final urine sample was
collected.
Analysis.
Visible fat and connective tissue were removed from the muscle samples,
which were then quenched in liquid nitrogen and subsequently stored at
70°C. The
L-[13C]leucine
enrichment in mixed muscle protein was determined by using gas
chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS)
as described by Yarasheski et al. (29). Blood was analyzed for plasma
glucose [kit 315, coeffiicient of variation (CV) = 3.9%, Sigma
Diagnostics, St. Louis MO] and insulin concentration (radioimmunoassay, CV = 2.9%, Diagnostic Products, Los Angeles, CA).
Plasma
-[13C] ketoisocaproic
acid (
-KIC) was prepared as the trimethylsilyl-quinoxalinol derivative. Its isotopic enrichment was determined with the use of
electron-impact ionization capillary gas chromatography/mass spectrometry (GC/MS) by using selected ion monitoring of mass-to-charge ratio 233/232. Urinary urea nitrogen and creatinine excretion were
determined from aliquots of the 24-h urine collections by using
colorimetric methods as described by Tarnopolsky et al. (23) (kits 640 and 555, CV = 4.7 and <1%, respectively, Sigma Diagnostics). 3-MH
concentration was determined by using an automated amino acid analyzer
and was normalized to the 24-h urinary creatinine excretion (Beckman
Instruments, Palo Alto, CA).
Calculations.
Muscle FSR was calculated according to the equation
|
-[13C]KIC
enrichment for t = 2.5-, ~10-, and
~10.5-h blood samples (corrected for natural abundance of
-[13C]KIC in the
t = 0-h blood sample). Leucine flux
(
) was calculated by using the reciprocal pool
model (8), at isotopic plateau
|
1 · h
1),
Ei is enrichment of the infused
leucine, Ep is enrichment of the
plasma
-[13C]KIC
(atom percent excess), and the term "
1"
corrects for the contribution of the infused isotope to
. The rate of whole body protein degradation (WBPD)
was estimated from
based on the equation
|
.
Statistical analysis.
Muscle and blood data were analyzed by using repeated-measures analysis
of variance (time × treatment; GB-STAT version 5.30, Dynamic
Microsystems). When a significant interaction occurred, Tukey's post
hoc analysis was used to locate the pairwise differences. Area under
the curve (insulin, glucose) was calculated with a custom-made software
package. Urine and area under the curve data were analyzed by using
paired t-tests.
P < 0.05 was selected as being
indicative of statistical significance. Values are expressed as means ± SE.
There were no differences in plasma insulin concentrations at the
beginning (t =
1.5 h) and end
of the infusion (t = ~10 h; CV = 2.9%). Plasma insulin concentrations were significantly higher for the
CHO compared with the Pl condition at the +0.5-, +0.75-, +1.25-, +1.5-,
+1.75-, and +2.0-h time points (P < 0.01) (Fig. 1). The area under the insulin
curve over the first 2.5 h was ~4 times greater for the CHO condition
compared with Pl [65.2 ± 12.1 µIU · h
1 · ml
1
for CHO and 15.2 ± 2.1 µIU · h
1 · ml
1
for Pl (P < 0.01)] (Fig.
2).
) and placebo (Pl;
) with respect to time. Values are means ± SE;
n = 8. * P < 0.01 between 2 conditions.
Plasma glucose concentrations were not significantly different between
CHO and Pl before the beginning of
(t =
1.5 h) and at
the end of the isotope infusion (Fig. 3).
At the completion of exercise, plasma glucose levels were greater than
baseline values for both the CHO and Pl conditions [6.26 ± 0.40 to 6.73 ± 0.54 mmol/l for CHO and 5.70 ± 0.55 to 6.50 ± 0.25 mmol/l for Pl (P < 0.05)]. Plasma glucose concentration was also significantly higher (P < 0.01) at +0.5 and +0.75
h in the CHO condition compared with Pl. The area under the curve for
glucose in the first 2.5 h was significantly greater for CHO compared
with Pl (P < 0.01; CHO = 7.21 ± 0.43 mmol · h
1 · l
1
and Pl = 5.88 ± 0.16 mmol · h
1 · l
1)
(Fig. 4).
) and Pl (
) with respect to
time. Values are means ± SE; n = 8. * P < 0.05 between 2 conditions.
Twenty-four-hour urinary creatinine excretion was not significantly
different between the two conditions
(n = 7; 1.76 ± 0.15 g/24 h for CHO
and 1.70 ± 0.09 g/24 h for Pl). Because these values were not
significantly different, the remainder of the urinary results were
expressed relative to the creatinine values. 3-MH excretion was
significantly lower for the CHO condition vs. Pl (P < 0.05;
n = 7; 110.43 ± 3.62 and 120.14 ± 5.82 µmol/g creatinine, respectively) (Fig.
5A). A
similar difference was observed for urinary urea nitrogen
(P < 0.05;
n = 7; CHO = 8.60 ± 0.66 g/g creatinine and Pl = 12.28 ± 1.84 g/g creatinine) (Fig.
5B).
Plasma
-[13C]KIC
enrichment at each sampling point is shown in Fig.
6 (n = 7).
Isotopic equilibrium was achieved for each individual subject [CV = <10%, slope = not significant (NS)] and maintained for the duration
of the infusion, as expected from previous work (24).
-KIC) enrichment across time. Values are
means ± SE; n = 6. APE, atom
%excess.
Compared with the control leg muscle, FSR in the exercised vastus
lateralis muscle was elevated by 36.1% in the CHO condition and by
6.3% in the Pl condition (NS; n = 6)
(Fig. 7).
No significant difference was observed for whole body leucine flux
between the two conditions (n = 7;
115.37 ± 5.65 µmol · kg
1 · h
1
for CHO and 113.07 ± 4.05 µmol · kg
1 · h
1
for Pl).
The purpose of this investigation was to determine the effect of glucose supplementation timing when given immediately after a bout of resistance exercise on FSR, MPD, WBPD, and urinary urea excretion. A glucose supplement of 1 mg/kg (immediately and +1 h postexercise) resulted in a significant increase in plasma glucose and insulin concentrations as seen by others (9, 32). This was associated with less urinary 3-MH and urea nitrogen excretion, with no difference in vastus lateralis FSR or WBPD. The net effect was anabolic and would result in a more positive net muscle protein balance.
Most of the work in the area of insulin and its effects on protein turnover has involved the use of insulin and glucose infusions (3, 13, 14, 17). The present study is the first report in humans of the influence of oral glucose supplementation on post-resistance-exercise protein metabolism and has practical implications for athletes and persons performing therapeutic exercise. The positive effects of supplementation on protein metabolism were achieved from a simple redistribution of the timing of the subject's habitual caloric intake.
The administration of a CHO drink led to a significant decrease in urinary 3-MH excretion over the day of the study. We interpreted this as a reduction in MPD. This finding is supportive of some (13, 18) but not all (3, 14) previous studies of the effect of elevated insulin on MPD. An advantage of 24-h urinary 3-MH excretion over the arteriovenous balance technique is the length of time over which the determination occurs. The longer collection duration for the urinary excretion method is advantageous in assessing MPD over the entire postexercise recovery period and thus is useful in determining the impact of an intervention on WBPD. Others have also considered 3-MH to be indicative of MPD (5, 27, 31).
Concerns about the validity of 3-MH excretion as an indicator of MPD relate primarily to the contribution of nonmuscle sources (skin/splanchnic/dietary) to the 3-MH pool (20). Two other sources of error in using 3-MH determinations are a lack of dietary controls and failure to account for interindividual differences in the ratio of nonmyofibrillar/myofibrillar contributions to total urinary 3-MH excretion (10, 20, 27). In the present study, the subjects were on a controlled flesh-free diet for 3 days before each trial and a prepackaged flesh-free diet on the day of each trial (10). Furthermore, we used a crossover repeated-measures design and, therefore, the interindividual variation in contribution from skeletal muscle vs. non-skeletal muscle protein to urinary 3-MH would be constant.
It has been demonstrated in humans with infection that the contribution of splanchnic sources to the 3-MH pool is relatively small during periods of extensive catabolism (21, 22). On the other hand, under periods of hyperinsulinemia and hyperaminoacidemia there appears to be a reduction in nonmyofibrillar protein breakdown in resting humans (14). However, in the postexercise state, when protein breakdown is increased (4), it is not known whether insulin attenuates this in myofibrillar proteins.
In summary, the provision of a glucose supplement immediately post-resistance exercise decreases urinary 3-MH excretion. Without arteriovenous differences measurements, the source of this reduction cannot be ascertained with certainty.
The decrease in 3-MH excretion was accompanied by significantly lower urinary urea nitrogen excretion, which suggested a reduction in amino acid transamination and oxidative deamination because urinary urea excretion is determined by the concentration of urea in the plasma and the glomerular filtration rate (7). We assumed that the glomerular filtration rate for each subject was similar between trials because dietary energy, protein, fluid intake, and exercise were identical for each condition. Furthermore, there were no differences in creatinine excretion, and both urea and 3-MH were expressed relative to this. Thus, assuming that sweat and fecal loss did not differ between the two trials (19, 25), whole body nitrogen balance would be more positive for the CHO condition.
Differences in WBPD were not observed between conditions. It appears the CHO treatment did not provide enough of a reduction in MPD to influence WBPD. However, FSR contributes ~25% to WBPS (15), and one could estimate that only ~7% of the total muscle mass was active during the exercise. Therefore, changes in MPD may have contributed too little to influence WBPD due to a dilutional effect. A similar protocol with the use of a whole body exercise stimulus (vs. single leg) may have shown an effect of MPD on WBPD. Alternatively, protein degradation in non-skeletal muscle tissue (i.e., splanchnic) may have changed in an opposite direction and attenuated the influence of MPD on WBPD (28).
Furthermore, the WBPD measurements were taken from
-[13C]KIC collected
immediately postexercise and near the termination of the infusion
(t = +10 h; fasted state). It is
probable that for the CHO trial there was a reduction in WBPD during
the period of hyperinsulinemia postexercise (~2 h) and for the Pl
postbreakfast (2 g/kg CHO) (14). WBPD measurements would have
to have been taken for ~3 h after each of these time periods to
determine whether WBPD was more sensitive to the effect of insulin in
the postexercise period. The 3-MH data and the reduction in urea
excretion suggested that this may have been the case.
We found that the rates of FSR remained unchanged in response to the administration of CHO. A trend was observed in that the CHO condition led to a nonstatistically significant 36% increase in the difference between the exercise leg and the rest leg (Fig. 7). A positive effect of insulin on FSR has been described by others (3, 17). One factor that may have attenuated an increase in FSR was the fact that the glucose supplement likely caused a decrease in plasma amino acid availability due to elevated insulin. It has been demonstrated that the positive effect of insulin on FSR is seen predominantly with concomitant hyperaminoacidemia (2, 3, 17). Another factor that may have attenuated a positive response from the postexercise glucose supplement was the fact that the insulin was only significantly increased for ~2 h after the supplementation, whereas the incorporation time was 10 h. Future studies should use methods that can determine FSR over a period of ~4 h (3, 4).
Unforeseen sampling errors led to a decrease in the sample size for the FSR analysis (n = 6). Therefore, a type II error may also explain the lack of significant increase. In addition, the exercise stimulus might not have been sufficient to stimulate an increase in FSR in the vastus lateralis. We have previously reported an increase in FSR by using a greater volume of training in a fusiform muscle (biceps brachii) after training (6). Because the vastus lateralis is a pennate muscle that contributes to both knee stabilization and extension, the force/unit area may have been less than in our previous study using the biceps brachii. A study of female swimmers also found no effect of resistance exercise on FSR by using a muscle that is difficult to fully activate (posterior deltoid) (26). This same group, however, found an increase in FSR in the vastus lateralis by using an almost identical intensity and volume of resistance exercise (4). It should be noted, however, that the subjects in the latter study were untrained (4), and it is possible that this may partially explain the discrepant results. A third possibility is that our measurement of FSR over a 10-h period immediately after exercise may not have included the time points over which FSR is maximal. We know from previous studies that FSR appears to peak at ~24 h after exercise (12).
In summary, our results indicate that consumption of a 1 g/kg CHO supplement immediately and 1 h after completion of a resistance training bout significantly decreased myofibrillar protein breakdown and urinary urea nitrogen excretion, and slightly increased FSR, resulting in a more positive protein balance. This suggests that consumption of a glucose supplement after resistance exercise increases insulin concentration and thus may enhance muscle protein balance.
The authors thank Dr. E. V. Youglai and Marty Gibala for help and technical support.
Address for reprint requests: M. A. Tarnopolsky, Dept. of Neurology and Physical Medicine and Rehabilitation, Rm 201B, Ivor Wynne Centre, McMaster Univ., Hamilton, Ontario, Canada L8S 4K1.
Received 16 September 1996; accepted in final form 10 February 1997.
| 1. |
Balon, T. W.,
A. Zorzano,
J. L. Treadway,
M. N. Goodman,
and
N. B. Ruderman.
Effect of insulin on protein synthesis and degradation in skeletal muscle after exercise.
Am. J. Physiol.
258 (Endocrinol. Metab. 21):
E92-E97,
1990 .
|
| 2. |
Bennet, W. M.,
A. A. Connacher,
C. M. Scrimgeour,
R. T. Jung,
and
M. J. Rennie.
Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissue during hyperaminoacidemia.
Am. J. Physiol.
259 (Endocrinol. Metab. 22):
E185-E194,
1990 .
|
| 3. | Biolo, G., R. Y. D. Flemming, and R. R. Wolfe. Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J. Clin. Invest. 95: 811-819, 1995 . |
| 4. |
Biolo, G.,
S. P. Maggi,
B. D. Williams,
K. D. Tipton,
and
R. R. Wolfe.
Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans.
Am. J. Physiol.
268 (Endocrinol. Metab. 31):
E514-E520,
1995 .
|
| 5. |
Carraro, F.,
C. S. Stuart,
W. H. Hartl,
J. Rosenblatt,
and
R. R. Wolf.
Effect of exercise and recovery on muscle protein synthesis in human subjects.
Am. J. Physiol.
259 (Endocrinol. Metab. 22):
E470-E476,
1990 .
|
| 6. |
Chesley, A.,
J. D. MacDougall,
M. A. Tarnopolsky,
S. A. Atkinson,
and
K. Smith.
Changes in human muscle protein synthesis after resistance exercise.
J. Appl. Physiol.
73:
1383-1388,
1992
|
| 7. | Guyton, A. C., and J. E. Hall. Textbook of Medical Physiology. Philadelphia, PA: Saunders, 1996. |
| 8. |
Horber, F. F.,
C. M. Harber-Feyder,
S. Krayer,
W. F. Schwenk,
and
M. W. Hamond.
Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis.
Am. J. Physiol.
257 (Endocrinol. Metab. 20):
E385-E399,
1989 .
|
| 9. |
Ivy, J. L.,
A. L. Katz,
C. L. Cutler,
W. M. Sherman,
and
E. F. Coyle.
Muscle glycogen synthesis after exercise: effect of time of carbohydrate ingestion.
J. Appl. Physiol.
64:
1480-1485,
1988
|
| 10. |
Lukaski, H. C.,
J. Mendez,
E. R. Buskirk,
and
S. H. Cohn.
Relationship between endogenous 3-methylhistidine excretion and body composition.
Am. J. Physiol.
240 (Endocrinol. Metab. 3):
E302-E307,
1981 .
|
| 11. | MacDougall, J. D. Hypertrophy or hyperplasia. In: Strength and Power in Sport, edited by P. V. Komi. Boston, MA: Blackwell, 1992, p. 230-238. |
| 12. | MacDougall, J. D., M. J. Gibala, M. A. Tarnopolsky, J. R. MacDonald, S. A. Interisano, and K. E. Yarasheski. The time course for elevated muscle protein synthesis following heavy resistance exercise. Can. J. Appl. Physiol. 20: 480-486, 1995 [Medline] . |
| 13. |
McNurlan, M. A.,
P. Essen,
A. Thorell,
A. G. Calder,
S. E. Anderson,
O. Ljungqvist,
A. Sandgren,
I. Grant,
I. Tjader,
P. E. Ballmer,
J. Wernerman,
and
P. J. Garlick.
Response of protein synthesis in human skeletal muscle to insulin: an investigation with L-[2H5] phenylalanine.
Am. J. Physiol.
267 (Endocrinol. Metab. 30):
E102-E108,
1994 .
|
| 14. |
Moller-Loswick, A. C.,
H. Zachrisson,
A. Hyltander,
U. Korner,
D. E. Matthews,
and
K. Lundholm.
Insulin selectively attenuates breakdown of nonmyofibrillar proteins in peripheral tissues of normal men.
Am. J. Physiol.
266 (Endocrinol. Metab. 29):
E645-E652,
1994 .
|
| 15. |
Nair, K. S.,
D. Halliday,
and
R. C. Griggs.
Leucine incorporation into mixed skeletal muscle protein in humans.
Am. J. Physiol.
254 (Endocrinol. Metab. 17):
E208-E213,
1988 .
|
| 16. | Nauck, M. A., H. Lieb, E. G. Siegel, P. D. Niedmann, and W. Creutzfeldt. Critical evaluation of the "heated-hand-technique" for obtaining "arterialized" venous blood: incomplete arterialization and alterations in glucagon responses. Clin. Physiol. 12: 537-552, 1992 . [Medline] |
| 17. | Newman, E., M. J. Heslin, R. F. Wolf, P. W. T. Pisters, and M. F. Brennan. The effect of systemic hyperinsulinemia with concomitant amino acid infusion on skeletal muscle protein turnover in the human forearm. Metabolism 43: 70-78, 1994 . [Medline] |
| 18. | Pacy, P. J., K. S. Nair, C. Ford, and D. Halliday. Failure of insulin to stimulate fractional muscle protein synthesis in type-I diabetic patients. Diabetes 38: 618-624, 1989 . [Abstract] |
| 19. |
Phillips, S. M.,
S. A. Atkinson,
M. A. Tarnopolsky,
and
J. D. MacDougall.
Gender differences in leucine kinetics and nitrogen balance in endurance athletes.
J. Appl. Physiol.
75:
2134-2141,
1993
|
| 20. | Rennie, M. J., and D. J. Millward. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown. Clin. Sci. (Lond.) 65: 217-225, 1983 . [Medline] |
| 21. |
Sjölin, J.,
H. Stjernström,
G. Arturson,
E. Andersson,
G. Friman,
and
J. Larsson.
Exchange of 3-methylhistidine in the splanchic region in human infection.
Am. J. Clin. Nutr.
50:
1407-1414,
1989 .
|
| 22. | Sjölin, J., H. Stjernström, S. Henneberg, E. Andersson, J. Mörtensson, G. Friman, and J. Larsson. Splanchic and peripheral release of 3-methylhistidine in relation to its urinary excretion in human infection. Metabolism 38: 23-29, 1989 . [Medline] |
| 23. |
Tarnopolsky, M. A.,
S. A. Atkinson,
J. D. MacDougall,
A. Chesley,
S. Phillips,
and
H. P. Schwarcz.
Evaluation of protein requirements for trained strength athletes.
J. Appl. Physiol.
73:
1986-1995,
1992
|
| 24. | Tarnopolsky, M. A., S. A. Atkinson, J. D. MacDougall, B. B. Senor, P. W. R. Lemon, and H. Schwarcz. Whole body leucine metabolism during and after resistance exercise in fed humans. Med. Sci. Sports Exercise 23: 326-333, 1991 . [Medline] |
| 25. |
Tarnopolsky, M. A.,
J. D. MacDougall,
and
S. A. Atkinson.
Influence of protein intake and training status on nitrogen balance and lean body mass.
J. Appl. Physiol.
64:
187-193,
1988
|
| 26. |
Tipton, K. D.,
A. A. Ferrando,
B. D. Williams,
and
R. R. Wolfe.
Muscle protein metabolism in female swimmers during recovery from swim and resistance training.
J. Appl. Physiol.
81:
2034-2038,
1996
|
| 27. |
Virgili, F.,
G. Maiani,
H. Zahoor,
D. Ciarapica,
A. Raguzzini,
and
A. Ferro-Luzzi.
Relationship between fat-free mass and urinary excretion of creatinine and 3-methylhistidine in adult humans.
J. Appl. Physiol.
76:
1946-1950,
1994
|
| 28. |
Williams, B. D.,
R. R. Wolfe,
D. Bracy,
and
D. H. Wasserman.
Gut proteolysis provides essential amino acids during exercise.
Am. J. Physiol.
270 (Endocrinol. Metab. 33):
E85-E90,
1996 .
|
| 29. | Yarasheski, K. E., K. Smith, M. J. Rennie, and D. M. Bier. Measurement of muscle protein fractional synthetic rate by capillary gas chromatography/combustion isotope ratio mass spectrometry. Biol. Mass Spectr. 21: 486-490, 1992 . [Medline] |
| 30. |
Yarasheski, K. E.,
J. J. Zachwieja,
and
D. M. Bier.
Acute effect of resistance exercise on muscle protein synthesis rate in young and elderly men and women.
Am. J. Physiol.
265 (Endocrinol. Metab. 28):
E210-E214,
1993 .
|
| 31. | Young, V. R., and H. N. Munro. 3-Methylhistidine and muscle protein turnover: an overview. Federation Proc. 37: 2291-2300, 1978 . [Medline] |
| 32. |
Zawadzki, K. M.,
B. B. Yaspelkis,
and
J. L. Ivy.
Carbohydrate complex increases the rate of muscle glycogen storage after exercise.
J. Appl. Physiol.
72:
1854-1859,
1992
|
This article has been cited by other articles:
![]() |
R. Koopman and L. J. C. van Loon Aging, exercise, and muscle protein metabolism J Appl Physiol, June 1, 2009; 106(6): 2040 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Drummond, H. C. Dreyer, C. S. Fry, E. L. Glynn, and B. B. Rasmussen Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling J Appl Physiol, April 1, 2009; 106(4): 1374 - 1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B Verdijk, R. A. Jonkers, B. G Gleeson, M. Beelen, K. Meijer, H. H. Savelberg, W. K. Wodzig, P. Dendale, and L. J. van Loon Protein supplementation before and after exercise does not further augment skeletal muscle hypertrophy after resistance training in elderly men Am. J. Clinical Nutrition, February 1, 2009; 89(2): 608 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beelen, M. Tieland, A. P. Gijsen, H. Vandereyt, A. K. Kies, H. Kuipers, W. H. M. Saris, R. Koopman, and L. J. C. van Loon Coingestion of Carbohydrate and Protein Hydrolysate Stimulates Muscle Protein Synthesis during Exercise in Young Men, with No Further Increase during Subsequent Overnight Recovery J. Nutr., November 1, 2008; 138(11): 2198 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beelen, R. Koopman, A. P. Gijsen, H. Vandereyt, A. K. Kies, H. Kuipers, W. H. M. Saris, and L. J. C. van Loon Protein coingestion stimulates muscle protein synthesis during resistance-type exercise Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E70 - E77. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Morrison, D. Hara, Z. Ding, and J. L. Ivy Adding protein to a carbohydrate supplement provided after endurance exercise enhances 4E-BP1 and RPS6 signaling in skeletal muscle J Appl Physiol, April 1, 2008; 104(4): 1029 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Koopman, M. Beelen, T. Stellingwerff, B. Pennings, W. H. M. Saris, A. K. Kies, H. Kuipers, and L. J. C. van Loon Coingestion of carbohydrate with protein does not further augment postexercise muscle protein synthesis Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E833 - E842. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Koopman, L. Verdijk, R. J. Manders, A. P Gijsen, M. Gorselink, E. Pijpers, A. J. Wagenmakers, and L. J. van Loon Co-ingestion of protein and leucine stimulates muscle protein synthesis rates to the same extent in young and elderly lean men. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 623 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sheffield-Moore, D. Paddon-Jones, A. P. Sanford, J. I. Rosenblatt, A. G. Matlock, M. G. Cree, and R. R. Wolfe Mixed muscle and hepatic derived plasma protein metabolism is differentially regulated in older and younger men following resistance exercise Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E922 - E929. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Koopman, A. J. M. Wagenmakers, R. J. F. Manders, A. H. G. Zorenc, J. M. G. Senden, M. Gorselink, H. A. Keizer, and L. J. C. van Loon Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E645 - E653. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Rankin, L. P. Goldman, M. J. Puglisi, S. M. Nickols-Richardson, C. P. Earthman, and F. C. Gwazdauskas Effect of Post-Exercise Supplement Consumption on Adaptations to Resistance Training J. Am. Coll. Nutr., August 1, 2004; 23(4): 322 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Borsheim, M. G. Cree, K. D. Tipton, T. A. Elliott, A. Aarsland, and R. R. Wolfe Effect of carbohydrate intake on net muscle protein synthesis during recovery from resistance exercise J Appl Physiol, February 1, 2004; 96(2): 674 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Esmarck, J L Andersen, S Olsen, E A Richter, M Mizuno, and M Kjaer Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans J. Physiol., August 15, 2001; 535(1): 301 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
A G Williams, M van den Oord, A Sharma, and D A Jones Is glucose/amino acid supplementation after exercise an aid to strength training? Br. J. Sports Med., April 1, 2001; 35(2): 109 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.R. Lemon Beyond the Zone: Protein Needs of Active Individuals J. Am. Coll. Nutr., October 1, 2000; 19(90005): 513S - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hernandez, M. J. Fedele, and P. A. Farrell Time course evaluation of protein synthesis and glucose uptake after acute resistance exercise in rats J Appl Physiol, March 1, 2000; 88(3): 1142 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Rasmussen, K. D. Tipton, S. L. Miller, S. E. Wolf, and R. R. Wolfe An oral essential amino acid-carbohydrate supplement enhances muscle protein anabolism after resistance exercise J Appl Physiol, February 1, 2000; 88(2): 386 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Tipton, A. A. Ferrando, S. M. Phillips, D. Doyle Jr., and R. R. Wolfe Postexercise net protein synthesis in human muscle from orally administered amino acids Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E628 - E634. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Phillips, K. D. Tipton, A. A. Ferrando, and R. R. Wolfe Resistance training reduces the acute exercise-induced increase in muscle protein turnover Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E118 - E124. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Roy and M. A. Tarnopolsky Influence of differing macronutrient intakes on muscle glycogen resynthesis after resistance exercise J Appl Physiol, March 1, 1998; 84(3): 890 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Tarnopolsky, M. Bosman, J. R. Macdonald, D. Vandeputte, J. Martin, and B. D. Roy Postexercise protein-carbohydrate and carbohydrate supplements increase muscle glycogen in men and women J Appl Physiol, December 1, 1997; 83(6): 1877 - 1883. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |